Conjugate Vaccine Market - Global Industry 2024

Views:
 
Category: Entertainment
     
 

Presentation Description

The global conjugate vaccine market can be classified on the basis of product type, disease indication, pathogen type, patient type, and region. In terms of product type, the global conjugate vaccine market can be segmented into multivalent conjugate vaccines and monovalent conjugate vaccines.

Comments

Presentation Transcript

slide 1:

Conjugate Vaccine Market - Global Industry Analysis Size Share Growth Trends and Forecast 2017 - 2025 Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Conjugate Vaccine Market". This report likewise incorporates more illumination about fundamental review of the business including definitions requisitions and worldwide business sector industry structure. Conjugate vaccines are vaccines for infectious diseases. There are special polysaccharide coatings on some bacteria and viruses that help them to escape the immune system. An immature immune system can recognize these bacteria with the help of the conjugate vaccines as these vaccines link the special polysaccharide coatings to an organism by producing immunity and response. The examples of conjugate vaccines are meningococcal vaccine to prevent meningitis haemophilus influenzae type B Hib vaccine and pneumococcal vaccine. Increased revenue from the sale of meningococcal vaccines and pneumococcal vaccines are driving the global conjugate vaccine market due to increasing advancements in the research and development. Increasing prevalence of infectious diseases and rising awareness toward prevention of these disease is anticipated to boost the global conjugate vaccine market during

slide 2:

the forecast period. However long time interval between the introduction of new conjugate vaccines in low-income countries and high-income countries is likely to restrain the global conjugate vaccine market. According to the U.S. National Library of Medicine National Institutes of Health high mortality and morbidity are caused due to vaccine-preventable diseases. In 2010 87 of the population of high-income countries had pneumococcal conjugate vaccines in their immunization schedules whereas only 2 had pneumococcal conjugate vaccines in their immunization schedules among the total population of low-income countries. Browse Full Research Report on Conjugate Vaccine Market: https://www.transparencymarketresearch.com/conjugate-vaccine- market.html The global conjugate vaccine market can be classified on the basis of product type disease indication pathogen type patient type and region. In terms of product type the global conjugate vaccine market can be segmented into multivalent conjugate vaccines and monovalent conjugate vaccines. The monovalent conjugate vaccines segment held the major share of the market in 2016 due to the high awareness and high quality vaccines provided by key players. However the multivalent conjugate vaccines segment is anticipated to expand in the near future due to the improvements in technology and government initiatives.

slide 3:

In terms of disease indication the global conjugate vaccine market can be segmented into meningococcal diphtheria tetanus pertussis influenza pneumococcal and others. The diphtheria tetanus pertussis segment of the global conjugate vaccine market expanded in 2016 due to its high prevalence and highly contagious nature of the respiratory tract infection. The pneumococcal segment of the global conjugate vaccine market is anticipated to expand during the forecast period as it is the most attractive segment in the market in terms of technology. In terms of pathogen type the global conjugate vaccine market can be segmented into combination viral and bacterial conjugate vaccine viral conjugate vaccine and bacterial conjugate vaccine. In terms of patient type the market can be segmented into adults conjugate vaccine and pediatrics conjugate vaccine. The pediatrics conjugate vaccine segment held a major share of the global market in 2016 due to the high prevalence of infectious diseases among children. Geographically the global conjugate vaccine market can be segmented into Asia Pacific Europe North America Latin America and Middle East Africa. In terms of technology North America is projected to be the most attractive market for conjugate vaccine during the forecast period due to rise in demand for pneumococcal meningococcal vaccines and other

slide 4:

conjugate vaccines. The market in Asia Pacific is anticipated to expand during the forecast period due to increasing immunization initiatives by organizations such as GA VI and World Health Organization in emerging economies such as India and China. Increasing focus of major players on the market in India and governmental initiatives for infectious diseases are likely to fuel the demand for the conjugate vaccines in the region. Key players operating in the global conjugate vaccine market include Serum Institute of India Pvt. Ltd. Sanofi Pasteur Pfizer Inc. Novartis AG Neuron Biotech Merck Co. Inc. GlaxoSmithKline plc CSL Behring Biological E and Bharat Biotech. About Us Transparency Market Research TMR is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts researchers and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

slide 5:

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports. Contact Us Transparency Market Research State Tower 90 State Street Suite 700 Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: salestransparencymarketresearch.com Website: http://www.transparencymarketresearch.com

authorStream Live Help